Pre-Clinical Toxicity: Avoiding Common Mistakes in Early Development
Pharma IQ | 06/21/2010
Dr. Mitchell Friedman, Director of Toxicology at Takeda Pharmaceuticals, discusses pre-clinical toxicity and avoiding common mistakes in early development so as to secure patient safety and better ROI.
To continue reading this story Click Here